OncoVITA

Oncovita is a biotech company developing a disruptive virus-derived vaccine technology to treat multiple types of cancers. Our MeasovirTM platform was developed based on the safe and highly immunogenic measles virus vaccine, a vaccine with clinically proven oncolytic potential. This technology utilizes the natural anti-cancer and immunogenic properties of this harmless vaccine, making it a versatile platform to produce effective new cancer treatments and vaccines.